Clinical Trials in Portland

Showing 2761-2780 of 8,670 trials

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

NCT02639182

The purpose of this study was to evaluate the progression free survival (PFS), based on investigator radiologic review, of AGS-16C3F compared to axitinib in subjects with metastatic renal cell carcinoma.

Metastatic Renal Cell Carcinoma

Astellas Pharma Global Development, Inc.133 participantsStarted May 2016

Tucson, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +23 more locations

COMPLETEDPhase 1< 1 mile

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Neoplasms

Vincerx Pharma, Inc.110 participantsStarted Feb 2016

Springdale, Arkansas, United States • Louisville, Kentucky, United States • Silver Spring, Maryland, United States +13 more locations

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Find Trials by Condition in Portland

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

North American Prodromal Synucleinopathy Consortium

The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

A Study of ASP1951 in Subjects With Advanced Solid Tumors

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4